InsidersTradesSigma
Discover the full directors' dealings record of 한국유니온제약, a listed equity based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Healthcare sector, 한국유니온제약 has published 1 insider filings. Market capitalisation: €19.7bn. The latest transaction was disclosed on 9 March 2026 — Sale. Among the most active insiders: 황용문. The full history is accessible without an account.
FY ended December 2025 · cache